Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Innovate Biopharmaceuticals Inc. INNT

Healthcare Biotechnology
"Innovate Biopharmaceuticals Inc is a clinical stage biotechnology company. The company is engaged in developing novel medicines for an autoimmune/ inflammatory disease. It includes drug candidates for celiac disease, NASH, Crohn's, and ulcerative colitis."
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:INNT)

9 Meters Biopharma Provides Business Update and Reports Financial Results for the Second Quarter 2021

Accesswire August 12, 2021

9 Meters Biopharma, Inc. to participate in BMO Capital Markets' "Biopharma Spotlight Series: Innovation in GI"

Accesswire August 5, 2021

9 Meters Biopharma, Inc. Announces the Acquisition of Humanized Anti-GIP Monoclonal Antibody from Lobesity

Accesswire July 19, 2021

9 Meters Biopharma, Inc. To Present at the William Blair Biotech Focus Conference

Accesswire July 8, 2021

9 Meters Added to Russell 2000(R) and 3000(R) Indexes

Accesswire June 28, 2021

9 Meters Announces Initiation of Phase 2 VIBRANT Study of Vurolenatide for Short Bowel Syndrome

Accesswire June 14, 2021

9 Meters Biopharma, Inc. to Present at 2021 BIO Digital

Accesswire June 9, 2021

9 Meters Biopharma, Inc. to Present at the Jefferies Virtual Healthcare Conference

Accesswire June 1, 2021

9 Meters Biopharma, Inc. Announces Publication in Journal of Clinical Investigation Describing Successful Use of Larazotide for Treating Multisystem Inflammatory Syndrome in Children (MIS-C) resulting from COVID-19 Infection

Accesswire May 26, 2021
View More News ››

Opinion & Analysis (NDAQ:INNT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:INNT)

NMTR ....NR after yesrdys close...up a little but....

There's lots of shs O/S It's getting "pumped" Not my style No position
Iseneschal - September 27, 2022

new site with deep DD on NMTR

New site with Deep DD on NMTR: FrugalNorwegian.com - All information on 1 page - Catalyst countdown timer - Several videos to watch...
FrugalNorwegian - May 7, 2021

Double$

Enjoy doubling my original investment. 
Bagofhammers - January 29, 2021

Whats Going On Here?

Is it the Dec 21 PR on the COV19 evaluation of respiratory complications? Killing it afterhours as well.
Bagofhammers - January 5, 2021

LARGE INSIDER BUYING - PH3 DRUG

ADDED
CPPInvestments - December 15, 2020

9 Meters - Phase 3 drug / NMTR

Very large (recent) insider/fund buying
CPPInvestments - December 11, 2020
View more Bullboard ››

Bitget

Bitget

Bitget is a leading cryptocurrency exchange serving 20+ million users in 100+ countries and processing daily trading volume ...
View More »